Literature DB >> 20734940

Gmelinoside I, a new flavonol glycoside from Limonium gmelinii.

Zhanar A Kozhamkulova1, Mohamed M Radwan, Galiya E Zhusupova, Zharilkasin Zh Abilov, Saniya N Rahadilova, Samir A Ross.   

Abstract

Gmelinoside I (1), a new flavonol glycoside, was isolated and chemically characterized as 3,5,7,3',4',5'-hexahydroxy-3-O-alpha-D-galactopyranosylflavone from the aerial part of Limonium gmelinii Kuntze (Plumbaginaceae).. Other compounds were identified as (-)-epigallocatechin-3-O-gallate, myricetin, myricetin-3-O-alpha-L-rhamnopyranoside, myricetin-3-O-beta-D-galactoside-6"-O-gallate and caprolactam. The antibacterial, antifungal and antileishmanial activities of the isolated compounds were evaluated. Myricetin showed moderate antileishmanial activity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20734940

Source DB:  PubMed          Journal:  Nat Prod Commun        ISSN: 1555-9475            Impact factor:   0.986


  2 in total

1.  Hepatoprotective effects of Limonium tetragonum, edible medicinal halophyte growing near seashores.

Authors:  Min Hye Yang; Na-Hyun Kim; Jeong-Doo Heo; Sang Hyun Sung; Eun Ju Jeong
Journal:  Pharmacogn Mag       Date:  2014-08       Impact factor: 1.085

2.  Chemical and biological investigations of Limonium axillare reveal mechanistic evidence for its antidiabetic activity.

Authors:  Essam Abdel-Sattar; Manal M Shams; Marwa M Abd-Rabo; Nehad Mahmoud; Engy A Mahrous
Journal:  PLoS One       Date:  2021-08-06       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.